MicroPort Scientific: An Odyssey Starting with Coronary Stents

Wei Zhang (First Author), Leiping Xu (Participant Author), Hongli Hang (Participant Author)

Research output: Contribution to journalJournal


The case was prepared by Associate Professor Zhang Wei of Peking University, Research Fellow Xu Leiping of China Europe International Business School, and Associate Professor Hang Hongli of Shanghai International Studies University with the helpful collaboration and support of Micro-Port Company. The case was developed to provide the basis of classroom discussion rather than to illustrate an effective or ineffective handling of a management situation. With the aim of illustrating an innovation model in an emerging market, this case summarizes the successful launch of drug-eluting stents at MicroPort and the development of innovation capabilities and culture within the company. The case also demonstrates a strategic dilemma after one round of effective technology innovation and, more important, the role of understanding the value system related to health care in sustaining innovation.
Original languageEnglish
Pages (from-to)377-417
JournalAsian Case Research Journal
Issue number2
Publication statusPublished - 2015

Indexed by

  • ABDC-C


Dive into the research topics of 'MicroPort Scientific: An Odyssey Starting with Coronary Stents'. Together they form a unique fingerprint.

Cite this